neuropeptide receptor blocker (Peptech/CRC)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameneuropeptide receptor blocker (Peptech/CRC)
Drug Alias Nameanticancer therapeutic (Peptech/CRC)growth factor inhibitor (Peptech/CRC)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuropeptide Y receptor type 2 antagonists
TargetsNeuropeptide Y receptor type 2
Therapy Area/IndicationsSmall Cell Lung CarcinomaSinusitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Clinical)
Highest Status in ChinaN/A
Originator CompaniesArana Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArana Therapeutics LtdCooperative Research Centre (Crc) For Biopharmaceutical Research
Active IndicationsN/A
Inactive IndicationsSmall Cell Lung CarcinomaSinusitis

Other Information

ATC CodeN/A
Related LinksN/A